Search

everythinglearnresearchcommunity

for

Search:↓

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Neurosteroids show promise for treating epilepsy and more research is needed.

Three new finasteride solvates found, change forms under different drying conditions.

Testosterone, progesterone, and levonorgestrel change enzyme levels related to fat production in hamster skin, which could affect skin oil and acne.

Metformin taken during pregnancy increases SHBG in newborns but doesn't change other hormone levels in mothers or babies.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

HNG may help prevent the negative effects of chemotherapy on sperm production and white blood cell counts.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

Finasteride for hair loss may cause persistent sexual symptoms, depression, anxiety, and lower quality of life.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Finasteride treatment changes brain steroid levels and receptors, affecting brain function even after stopping treatment.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Finasteride's molecular and crystal structures help develop new drug formulations.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Melatonin and mitotane treatment led to hair re-growth in 62% of dogs with Alopecia X, but this was not always linked to normal hormone levels.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

The medication combination did not affect glucose tolerance but increased some cholesterol levels due to its estrogen component.

TRM21 helps control flavonoid production and root hair growth in Arabidopsis thaliana.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

Activating TSPO helps protect the retina from damage caused by high eye pressure in glaucoma.

Three drugs change mice's alcohol drinking patterns by affecting GABAA receptors.

Finasteride potentially treats hair loss by reducing DHT production.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Dutasteride is more efficient than finasteride, but individual results vary.

Finasteride effectively reduces hair loss by decreasing androgen levels.

Genetics and hormones cause hair loss; finasteride treats it safely.

Best results found using acetonitrile, water, and trifluoroacetic acid or methanol mixture.

Pre-operative hormone treatment for hypospadias surgery might improve outcomes, but more research is needed to confirm.